HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis-Reference-Cited by-同舟云学术

HeberNasvac, a Therapeutic Vaccine for Chronic Hepatitis B, Stimulates Local and Systemic Markers of Innate Immunity: Potential Use in SARS-CoV-2 Postexposure Prophylaxis

Published:2021-10-22 Issue:2 Volume:11 Page:59-70
ISSN:2231-5047
Container-title:Euroasian Journal of Hepato-Gastroenterology
language:en
Short-container-title:

Author:

Aguilar JC,Aguiar Jorge,García Gerardo,Uddin Mohammad H,Akbar Sheikh MF,Gonzalez Isabel,Cinza Zurina,Figueroa Nelvis,Penton Eduardo,Mahtab Mamun A,Fleites Yoel A,Bequet Monica,Marrero Elieser,Vizcaíno Maritania,Esquivel Idelsis,Diaz Marisol,Sin-Mayor Adriana,Garcia Maura,Martinez Sara M,Beato Abrahan,Galarraga Ana G,Mendoza-Mari Yssel,Valdés Iris,Lemos Gilda,Canaán-Haden Camila,Oquendo Rachel,Guillén Gerardo E,Muzio Verena L

Publisher

Jaypee Brothers Medical Publishing

Link

https://www.ejohg.com/doi/pdf/10.5005/jp-journals-10018-1344

Reference51 articles.

1. 1. Bugra A, Das T, Arslan MN, et al. Postmortem pathological changes in extrapulmonary organs in SARS-CoV-2 rt-PCR–positive cases: a single-center experience. Irish J Med Sci (1971) 2021:1–11. DOI: 10.1007/s11845-021-02638-8.

2. 2. Damiani S, Fiorentino M, De Palma A, et al. Pathological post-mortem findings in lungs infected with SARS-CoV-2. J Pathol 2021;253(1): 31–40. DOI: 10.1002/path.5549.

3. 3. Walensky RP, Del Rio C. From mitigation to containment of the COVID-19 pandemic: putting the SARS-CoV-2 genie back in the bottle. JAMA 2020;323(19):1889–1890. DOI: 10.1001/jama.2020.6572.

4. 4. Sultana J, Crisafulli S, Gabbay F, et al. Challenges for drug repurposing in the COVID-19 pandemic era. Front Pharmacol 2020;11:588654. DOI: 10.3389/fphar.2020.588654.

5. 5. Chaudhry R, Dranitsaris G, Mubashir T, et al. A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes. EClinicalMedicine. 2020:100464. DOI: 10.1016/j.eclinm.2020.100464.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparing for the Next Pandemic: Increased Expression of Interferon-Stimulated Genes After Local Administration of Nasalferon or HeberNasvac;DNA and Cell Biology;2023-12-21

2. Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B;Vaccines;2022-12-07

3. The role of B cells in COVID-19 infection and vaccination;Frontiers in Immunology;2022-08-30

4. Photodynamic Therapy in Combination with the Hepatitis B Core Virus-like Particles (HBc VLPs) to Prime Anticancer Immunity for Colorectal Cancer Treatment;Cancers;2022-05-31

5. Innate Immune Stimulation Should not be Overlooked in Post-exposure Prophylaxis and Early Therapy for Coronavirus Infections;MEDICC Review;2022-01-18